Immunicon Corporation is developing and commercializing proprietary cell-based research and human diagnostic products with an initial focus on cancer disease management. The Company has developed platform technologies for selection and analysis of rare cells in blood, such as tumor cells. Immunicon's products and technology platforms also have applications in other field of medicine.
3401 Masons Mill Road
Huntingdon Valley, PA 19006